Most approval committees drown because they evaluate every request against a dozen criteria and apply them inconsistently. Three tests, applied in order, produce fast and defensible decisions.
Test 1: Data sensitivity
Start with what data the tool will actually touch, not what category the vendor occupies. A security review should cover public chatbots, embedded AI assistants in productivity suites, developer coding assistants, AI browser extensions, internal models and autonomous agents connected to enterprise systems (Zscaler). The risk follows the access, not the label: a chatbot wired into customer records may be riskier than a public tool used for generic brainstorming.
Pair this test with your data classification policy. One institution's generative AI policy permits public and, in some cases, internal data, prohibits restricted or confidential data, and forbids uploading copyrighted material without permission (ICOM policy). That kind of line is enforceable because it maps to labels employees already know.
Decision rule: a tool that cannot be configured to exclude restricted and confidential data fails automatically, regardless of features. Do not negotiate on this test.
Test 2: Integration and exit cost
The second test is what it costs to leave. Ask for the export format, the retention window, and whether the tool stores prompts in a form you can delete on request. A tool that becomes a system of record for prompts and outputs is much harder to remove than one that produces a document you save elsewhere.
This test also covers integration. A tool that duplicates an approved capability creates a second data store, a second audit trail and a second set of permissions to reconcile. Repeated shadow IT patterns are best read as signals about friction in the existing stack: slow systems, missing capabilities, clumsy integrations and rigid approval processes (Centric Consulting).
Test 3: Vendor transparency
The third test is whether the vendor will put its claims in writing. "We never train on your data" costs nothing to write, which is why serious reviews have moved on to the parts a buyer can check: named subprocessors, retention quoted in days, and a closed anonymized-data carve-out (Parseur). DataGrail's Privacy and AI Trends Report, which analyzed 2,400 popular business software providers, found that 63.6% of vendors advertising AI capabilities do not disclose a third-party AI subprocessor anywhere in their legal documentation (Parseur).
Enterprise agreements help, but they do not erase every question. OpenAI states that it does not train on business data by default, that customers own inputs and outputs, and that automated content classifiers may process submitted data (OpenAI enterprise privacy). It also notes that business data is only subject to human review on a service-by-service basis, which is exactly the kind of sentence a reviewer should pin down per product rather than assume across a vendor's whole catalog.
GitHub's disclosure around Copilot is a useful template for the opposite posture: it states that Business and Enterprise agreements prohibit using Copilot interaction data for model training, while individual users can opt out through account settings (GitHub community FAQ). A vendor that draws the account-tier line explicitly is easier to approve than one that asks you to trust a marketing page.
| Test | Pass | Fail | What to ask for |
|---|
| Data sensitivity | Can exclude restricted and confidential data | Cannot be configured, or no DPA | Data classification matrix, configuration guide |
| Integration and exit cost | Documented export, stated retention, deletable on request | No export path, unclear retention | Export sample, retention in days |
| Vendor transparency | Names subprocessors, quotes retention, signs DPA | No subprocessor disclosure, vague terms | DPA, subprocessor list, trust center report |
Any tool that passes all three moves to the allowlist. Any tool that fails one goes to the exception process described below. Do not run a fourth test during the meeting; run it in the quarterly review.